Your browser doesn't support javascript.
loading
Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and Nivolumab.
Lin, Andrew L; Jonsson, Philip; Tabar, Viviane; Yang, T Jonathan; Cuaron, John; Beal, Katherine; Cohen, Marc; Postow, Michael; Rosenblum, Marc; Shia, Jinru; DeAngelis, Lisa M; Taylor, Barry S; Young, Robert J; Geer, Eliza B.
Afiliação
  • Lin AL; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Jonsson P; Weill Cornell Medical College, New York, New York.
  • Tabar V; Multidisciplinary Pituitary and Skull Base Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Yang TJ; Marie-Josée and Henry R. Kravis Center for Molecular Oncology Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cuaron J; Weill Cornell Medical College, New York, New York.
  • Beal K; Multidisciplinary Pituitary and Skull Base Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cohen M; Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Postow M; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rosenblum M; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Shia J; Multidisciplinary Pituitary and Skull Base Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • DeAngelis LM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Taylor BS; Weill Cornell Medical College, New York, New York.
  • Young RJ; Multidisciplinary Pituitary and Skull Base Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Geer EB; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
J Clin Endocrinol Metab ; 103(10): 3925-3930, 2018 10 01.
Article em En | MEDLINE | ID: mdl-30085142

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Adenoma / Adenoma Hipofisário Secretor de ACT Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Adenoma / Adenoma Hipofisário Secretor de ACT Idioma: En Ano de publicação: 2018 Tipo de documento: Article